Le Lézard
Classified in: Health, Science and technology
Subject: FVT

Accelerating Clinical Development through Design, Diversity & Digitalization in Oncology and Beyond, Upcoming Webinar Hosted by Xtalks


In this free webinar, attendees will gain insights into novel approaches to keep clinical development on track. Hear about how these strategies can boost diversity, equity and inclusion (DEI), from real-world examples to support trial designs that will enhance return on investment and adherence to key performance indicators. The panel of experts will discuss the importance of incorporating new data strategies and the impact of artificial intelligence on trial design and execution in the form of case studies and insights from around the industry.

TORONTO, April 30, 2024 /PRNewswire-PRWeb/ -- In this dynamic panel-type webinar, the expert speakers will explore how to speed drug development and improve return on investment (ROI) by adopting a "3-D" approach to trials focusing on design, diversity and digitalization.

The speakers will draw insights from what has worked and what still needs to be done, and how new tools, such as digital and mobile health and other innovative approaches, can lead the way.

Oncology trials present unique challenges and will be the focal point for this discussion, but the key insights the speakers will cover are applicable to a wide range of therapeutic areas. Therefore, attendance is recommended across all therapeutic areas, ranging from cardiovascular to neuroscience to rare disease and, in fact, any enrollment-challenged indications.

The need to improve geographical, racial, ethnic and other forms of diversity and inclusion in trials ? including new legislation and regulatory guidance documents to spur adoption of diverse trials ? has been at the forefront of the industry for several years.

The speakers will draw insights from what has worked and what still needs to be done, and how new tools, such as digital and mobile health and other innovative approaches, can lead the way. Again, oncology poses special challenges due to the rarity of patients in certain indications and limitations on the ways in which recruitment can occur, particularly during earlier trial phases and where patient-centric approaches may be hard to implement. With so many recent advances in the application of "big data" strategies and artificial intelligence to trial design and execution, the speakers will discuss concrete ways in which these novel approaches have impacted trials and pipelines.

With the perspective of a leading oncology CRO, the speakers will review case studies and aggregate insights with an eye toward improving trial outcomes and performance against key performance indicators (KPIs) by working within an ecosystem where the CRO, investigator sites, patient advocacy groups and industry-leading partners all contribute to a shared mission of accelerating getting new treatments to patients in need.

The panel will cover key questions about innovative approaches to keeping your trials on track to meet their timelines and other key performance indicators.

Register for this webinar today to gain insights into innovative approaches to keeping clinical development on track to meet timelines and other KPIs.

Join experts from Fortrea, Geoffrey Kannan, PhD, MD, Executive Medical Director, Head of Americas Oncology Therapeutic Area Expertise; Brian Dolan, Vice President, Artificial Intelligence and Machine Learning; Alicia M. Baker McDowell, DRSc, MS, EMBA, Head of Regulatory Strategy and Product Development Consulting; Melissa Harris, Head of Global Patient Recruitment and Engagement; and Clare Campbell-Cooper, Global Head, Digital Health and Innovation, for the live webinar on Thursday, May 16, 2024, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Accelerating Clinical Development through Design, Diversity & Digitalization in Oncology and Beyond.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com 

SOURCE Xtalks


These press releases may also interest you

at 15:05
Elastic , today announced new Elasticsearch benchmarking on the preview of Azure Cobalt 100 Arm-based virtual machines. This resulted in up to 37% higher throughput performance when using Epsv6 VMs compared to the Ampere Altra-based Epsv5 VMs on...

at 15:05
UiPath , a leading enterprise automation and AI software company, today announced an integration between the UiPath Business Automation Platform and Microsoft Copilot for Microsoft 365. The integration will enable joint customers to automate more...

at 15:05
Molecular Instruments, Inc. announced that the Patents Court of the High Court of England and Wales has ordered: (1) that two patents owned by Advanced Cell Diagnostics, Inc. (a Bio-Techne group company; NASDAQ: TECH) both be revoked; (2) that...

at 15:02
In a groundbreaking first, IDEMIA, the world-leading provider of secure identity and biometric solutions, announced today it has achieved certification for its mIDReader and Verify SDK to the International Standard Organization ISO 18013 Part 5:...

at 15:00
AI21, a leader in building foundation models and AI systems for the enterprise proudly unveils a new collaboration with Microsoft that will bring AI21's latest cutting-edge Jamba-Instruct model to the Microsoft Azure AI as part of its...

at 14:56
Temple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer's disease. This project is in collaboration with a highly respected Clinical Research Organization...



News published on and distributed by: